Abstract：Objective To analyze the relationship between the degree of lymph node metastasis in patients with thyroid papillary carcinoma (PTC) and the level of thyroglobulin (Tg), and to explore the significance and feasibility of preoperative Tg detection in PTC patients for the risk assessment of preoperative lymphatic metastasis. Methods Clinical complete data of 360 cases of PTC patients from January 2016 to December 2017 in Fujian Medical University Union Hospital were retrospectively analyzed, all patients had preoperatie test for Tg, and receired thyroideetony with neck dissectiou by the same group of doctors, according to the lymph node metastasis of postoperative, they were divided into no transfer group (N0 group), the central lymph node metastasis group (N1a group), lateral transfer analysis group (N1b group), the three groups of patients with preoperative differences in the levels of Tg were analyzed, and each group within the number of lymph node metastasis and the differences in the levels of Tg were analyzed. Results There were highly statistically significant differences in preoperative serum Tg levels between the three groups (P ＜ 0.01). Pairwise comparison was also statistically significant (all P < 0.05). The comparison of serum Tg level before operation between different T-staging was highly statistically significant (P ＜ 0.01). Among them, there was no significant difference in Tg level between T2 and T3, T2 and T4 staging patients (P > 0.05), while there were highly statistically significant differences in Tg level between the other groups (P ＜ 0.01). There were no significant correlation coefficients between the number of lymph node metastases in central and lateral neck metastases and the Tg level (r = 0.006, 0.161, P > 0.05). Conclusion The preoperative Tg level is correlated with the risk of lymph node metastasis in the central region and lateral neck lymph node metastasis in PTC patients, and has no significant correlation with the number of metastases. It can be used as a reference for the assessment of lymph node metastasis before surgery, and has certain value for the prediction of pathological T-staging.
王思思 王波 谢超 赵文新▲. 甲状腺乳头状癌淋巴结转移与甲状腺球蛋白的关系[J]. 中国医药导报, 2018, 15(35): 114-117.
WANG Sisi WANG Bo XIE Chao ZHAO Wenxin▲. The relationship between lymph node metastasis and thyroglobulin in thyroid papillary carcinoma. 中国医药导报, 2018, 15(35): 114-117.
[1] Ge MH，Jiang LH，Wen QL，et al. Preliminary screening and analysis of metastasis-related lncRNA and co-expressed papillary thyroid carcinoma mRNA [J]. Oncol Lett，2018， 16（3）：3715-3725.
[2] Liu Z，Zhang J，Gao J，et al. MicroRNA-4728 mediated regulation of MAPK oncogenic signaling in papillary thyroid carcinoma [J]. Saudi J Biol Sci，2018，25（5）：986-990.
[3] Sampathkumar G，Nair V，Menon UV，et al. A Comparison of Clinicopathological Characteristics and Short-Term Outcome of Papillary Thyroid Carcinoma with Tall Cell Histology and Classic Papillary Thyroid Carcinoma：A Single-Institution Experience [J]. Indian J Endocrinol Metab，2018，22（3）：405-409.
[4] Kamal MM，Kulkarni HR，Makde MM，et al. Can Fine Needle Aspiration Cytology be Used as a "Proxy Gold Standard" to Diagnose Tuberculous Mastitis? [J]. J Cytol，2018， 35（3）：159-162.
[5] Carling T，Long WD，Udelsman R. Controversy surrounding the role for routine central lymph node dissection for differentiated thyroid cancer [J]. Curr Opin Oncol，2010， 22（1）：30-34.
[6] Liu L，Huang F，Liu B，et al. Detection of distant metastasis at the time of ablation in children with differentiated thyroid cancer：the value of pre-ablation stimulated thyroglobulin [J]. J Pediatr Endocrinol Metab，2018，31（7）：751-756.
[7] Patell R，Mikhael A，Tabet M，et al. Assessing the utility of preoperative serum thyroglobulin in differentiated thyroid cancer：a retrospective cohort study [J]. Endocrine，2018，61（3）：506-510.
[8] Sager S，Hatipoglu E，Gunes B，et al. Comparison of day 3 and day 5 thyroglobulin results after thyrogen injection in differentiated thyroid cancer patients [J]. Ther Adv Endocrinol Metab，2018，9（6）：177-183.
[9] Park S，Jeon MJ，Oh HS，et al. Changes in Serum Thyroglobulin Levels After Lobectomy in Patients with Low-Risk Papillary Thyroid Cancer [J]. Thyroid，2018，28（8）：997-1003.
[10] Feldt-Rasmussen U，Verburg FA，Luster M，et al. Thyroglobulin autoantibodies as surrogate biomarkers in the management of patients with differentiated thyroid carcinoma [J]. Curr Med Chem，2014，21（32）：3687-3692.
[11] Alonso-Gordoa T，Diez JJ，Duran M，et al. Advances in thyroid cancer treatment latest evidence and clinical potential [J]. Ther Adv Med Oncol，2015，7（1）：22-38.
[12] 尹兴杰.甲状腺微小乳头状癌的被膜侵犯情况对T分期及中央组淋巴结转移的影响：1092例患者的回顾性研究[D].武汉：华中科技大学，2017.
[13] 郑向前，候秀坤，高明，等.2017年第二版NCCN甲状腺肿瘤指南解读[J].中国肿瘤临床，2018，45（1）：14-17.
[14] 王新玲，孙楠，徐子奇，等.乌鲁木齐地区部分正常人群甲状腺过氧化物酶抗体和甲状腺球蛋白抗体阳性临界值的确定[J].医学研究杂志，2016，45（9）：113-116.
[15] Kir G，Sarbay BC，Ozpek A. Cytodiagnosis of Primary Thyroid Lymphoma Coincident with Unnoticed Papillary Thyroid Carcinoma：A Case Report and Review of the Literature [J]. J Cytol，2018，35（3）：187-189.
[16] 林在楷，周琨，陆霁，等.ROC曲线分析miRNA-221/222作为侵袭性甲状腺乳头状癌诊断标志物的临床价值[J].癌症进展，2018，16（1）：49-52.
[17] 李艳菊，张春莉.甲状腺乳头状癌中Survivin、VEGF、EGFR的表达及临床意义分析[J].癌症进展，2016，14（10）：1025-1027.
[18] Sheikh AB，Akhtar A，Tariq U，et al. Skull Metastasis Extending to the Superior Sagittal Sinus：An Unfamiliar Presentation of Papillary Thyroid Carcinoma [J]. Cureus，2018，10（6）：e2738.
[19] Yi JW，Yoon SG，Kim HS，et al. Transoral endoscopic surgery for papillary thyroid carcinoma：initial experiences of a single surgeon in South Korea [J]. Ann Surg Treat Res，2018， 95（2）：73-79.
[20] 陈锐，魏涛，张明，等.甲状腺乳头状癌cNO患者颈侧区淋巴结转移规律的探讨[J].中华耳鼻咽喉头颈外科杂志，2012，47（8）：662-667.
[21] 谢楚平.预防性中央区淋巴结清扫对甲状腺乳头状癌复发率的影响探讨[J].中国医药科学，2017（24）：216-218.
[22] 陈鹏，宋长祥，陆武，等.首次131Ⅰ治疗前监测甲状腺球蛋白预测分化型甲状腺癌转移的临床价值[J].中华内分泌代谢杂志，2018，34（2）：102-105.
[23] 万华俊.分化型甲状腺癌颈中央区淋巴结转移相关因素分析[D].上海：上海交通大学，2014.
2018, Vol. 15 
京公网安备 11010502046598号